Published in Euro Surveill on January 13, 2011
The global ecology and epidemiology of West Nile virus. Biomed Res Int (2015) 1.21
Permissive summer temperatures of the 2010 European West Nile fever upsurge. PLoS One (2013) 1.11
Recent progress in West Nile virus diagnosis and vaccination. Vet Res (2012) 1.09
Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile disease. Int J Environ Res Public Health (2013) 1.08
Experimental infections of wild birds with West Nile virus. Viruses (2014) 1.01
Molecular epidemiology and evolution of West Nile virus in North America. Int J Environ Res Public Health (2013) 0.99
Efficacy of mosquito traps for collecting potential West Nile mosquito vectors in a natural Mediterranean wetland. Am J Trop Med Hyg (2012) 0.98
Experimental studies on comparison of the vector competence of four Italian Culex pipiens populations for West Nile virus. Parasit Vectors (2015) 0.93
Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop. BMC Infect Dis (2014) 0.93
Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. Viruses (2013) 0.91
The complex epidemiological scenario of West Nile virus in Italy. Int J Environ Res Public Health (2013) 0.90
Emergence of west nile virus lineage 2 in europe: a review on the introduction and spread of a mosquito-borne disease. Front Public Health (2014) 0.88
Epidemiology of West Nile disease in Europe and in the Mediterranean Basin from 2009 to 2013. Biomed Res Int (2014) 0.88
West Nile virus state of the art report of MALWEST Project. Int J Environ Res Public Health (2013) 0.87
Population seroprevalence study after a West Nile virus lineage 2 epidemic, Greece, 2010. PLoS One (2013) 0.87
Small molecule pan-dengue and West Nile virus NS3 protease inhibitors. Antivir Chem Chemother (2011) 0.86
West Nile viral infection of equids. Vet Microbiol (2013) 0.85
The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system. Arch Virol (2012) 0.83
Antibody responses in humans infected with newly emerging strains of West Nile Virus in Europe. PLoS One (2013) 0.82
Susceptibility of European jackdaws (Corvus monedula) to experimental infection with lineage 1 and 2 West Nile viruses. J Gen Virol (2014) 0.82
Predictive modeling of West Nile virus transmission risk in the Mediterranean Basin: how far from landing? Int J Environ Res Public Health (2013) 0.81
West nile virus. Transfus Med Hemother (2013) 0.81
West Nile virus positive blood donation and subsequent entomological investigation, Austria, 2014. PLoS One (2015) 0.81
West Nile virus neuroinvasive disease presenting with acute flaccid paralysis and bilateral sensorineural hearing loss. J Neurol (2011) 0.79
Pilot longitudinal mosquito surveillance study in the Danube Delta Biosphere Reserve and the first reports of Anopheles algeriensis Theobald, 1903 and Aedes hungaricus Mihályi, 1955 for Romania. Parasit Vectors (2016) 0.78
Spatio-Temporal Identification of Areas Suitable for West Nile Disease in the Mediterranean Basin and Central Europe. PLoS One (2015) 0.78
First report outside Eastern Europe of West Nile virus lineage 2 related to the Volgograd 2007 strain, northeastern Italy, 2014. Parasit Vectors (2015) 0.78
Animal viral diseases and global change: bluetongue and West Nile fever as paradigms. Front Genet (2012) 0.78
Monitoring of West Nile virus in mosquitoes between 2011-2012 in Hungary. Vector Borne Zoonotic Dis (2014) 0.77
West Nile Virus equine serosurvey in the Czech and Slovak republics. Vector Borne Zoonotic Dis (2013) 0.77
IFN-dependent and -independent reduction in West Nile virus infectivity in human dermal fibroblasts. Viruses (2014) 0.76
In Vitro and in Vivo Evaluation of Mutations in the NS Region of Lineage 2 West Nile Virus Associated with Neuroinvasiveness in a Mammalian Model. Viruses (2016) 0.76
West Nile Virus in Europe and Safety of Blood Transfusion. Transfus Med Hemother (2016) 0.75
Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III. Virology (2016) 0.75
West Nile Virus Seroprevalence in the Greek Population in 2013: A Nationwide Cross-Sectional Survey. PLoS One (2015) 0.75
An outbreak of West Nile Virus infection in the region of Monastir, Tunisia, 2003. Pathog Glob Health (2014) 0.75
Review of West Nile virus circulation and outbreak risk in Madagascar: Entomological and ornithological perspectives. Parasite (2016) 0.75
Transmission Dynamics of the West Nile Virus in Mosquito Vector Populations under the Influence of Weather Factors in the Danube Delta, Romania. Ecohealth (2016) 0.75
Reconstructing the recent West Nile virus lineage 2 epidemic in Europe and Italy using discrete and continuous phylogeography. PLoS One (2017) 0.75
Entomologic and avian investigations of an epidemic of West Nile fever in Romania in 1996, with serologic and molecular characterization of a virus isolate from mosquitoes. Am J Trop Med Hyg (1999) 4.62
Intracellular crowding defines the mode and sequence of substrate uptake by Escherichia coli and constrains its metabolic activity. Proc Natl Acad Sci U S A (2007) 2.42
Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect (2004) 2.30
Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation. Virology (1993) 2.20
Molecular characterization of human enteroviruses in clinical samples: comparison between VP2, VP1, and RNA polymerase regions using RT nested PCR assays and direct sequencing of products. J Med Virol (2001) 2.09
Generic RT-nested-PCR for detection of flaviviruses using degenerated primers and internal control followed by sequencing for specific identification. J Virol Methods (2005) 1.96
Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J Med Virol (1998) 1.90
A generic nested-RT-PCR followed by sequencing for detection and identification of members of the alphavirus genus. J Virol Methods (2001) 1.78
Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Euro Surveill (2010) 1.69
Recent expansion of dengue virus serotype 3 in West Africa. Euro Surveill (2010) 1.64
Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule. Eur J Immunol (1985) 1.60
West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention. Clin Microbiol Infect (2013) 1.58
Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death Dis (2013) 1.57
13C-phenylalanine and 13C-methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease. Dig Liver Dis (2000) 1.51
Detection of varicella-zoster virus-specific DNA sequences in cerebrospinal fluid from patients with acute aseptic meningitis and no cutaneous lesions. J Med Virol (1994) 1.49
A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010. Euro Surveill (2011) 1.45
SARS: retrospective cohort study among German guests of the Hotel 'M', Hong Kong. Euro Surveill (2003) 1.45
Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis (1994) 1.44
Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp. J Antimicrob Chemother (2009) 1.38
Enteroviruses in Spain: virological and epidemiological studies over 10 years (1988-97). Epidemiol Infect (2000) 1.35
Molecular identification of enterovirus by analyzing a partial VP1 genomic region with different methods. J Clin Microbiol (2002) 1.33
Use of a short fragment of the C-terminal E gene for detection and characterization of two new lineages of dengue virus 1 in India. J Clin Microbiol (2006) 1.32
Detection of enteroviral RNA and specific DNA of herpesviruses by multiplex genome amplification. J Virol Methods (1997) 1.31
Usutu virus: potential risk of human disease in Europe. Euro Surveill (2011) 1.30
Evaluation of a commercially available reverse transcription-PCR assay for diagnosis of enteroviral infection in archival and prospectively collected cerebrospinal fluid specimens. J Clin Microbiol (1998) 1.26
Multicenter quality assessment of PCR methods for detection of enteroviruses. J Clin Microbiol (1999) 1.23
Yellow fever vaccine-associated viscerotropic disease and death in Spain. J Clin Virol (2006) 1.21
Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect (2004) 1.18
Detection and monitoring of mosquito flaviviruses in Spain between 2001 and 2005. Vector Borne Zoonotic Dis (2009) 1.13
A survey on cases of tick-borne encephalitis in European countries. Euro Surveill (2008) 1.10
Epidemic West Nile encephalitis in Romania: waiting for history to repeat itself. Ann N Y Acad Sci (2001) 1.09
Two different PCR assays to detect enteroviral RNA in CSF samples from patients with acute aseptic meningitis. J Med Virol (1995) 1.08
Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe. Euro Surveill (2005) 1.08
Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages. J Virol (2002) 1.06
Effects of laser irradiation on human thrombus: demonstration of a linear dissolution-dose relation between clot length and energy density. Am J Cardiol (1983) 1.06
Removal of UroLume endoprosthesis: experience of the North American Study Group for detrusor-sphincter dyssynergia application. J Urol (2000) 1.06
Traumatic aneurysm of the basilar artery. AJNR Am J Neuroradiol (1996) 1.05
p38-mediated regulation of an Fas-associated death domain protein-independent pathway leading to caspase-8 activation during TGFbeta-induced apoptosis in human Burkitt lymphoma B cells BL41. Mol Biol Cell (2001) 1.05
Susceptibility of different eukaryotic cell lines to SARS-coronavirus. Arch Virol (2005) 1.04
B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking. J Immunol (1995) 1.04
Viral infections of the central nervous system in Spain: a prospective study. J Med Virol (2012) 1.04
The challenge of West Nile virus in Europe: knowledge gaps and research priorities. Euro Surveill (2015) 1.04
Proliferation and tissue remodeling in cancer: the hallmarks revisited. Cell Death Dis (2012) 1.03
HTLV-III infection in kidney transplant recipients. Lancet (1985) 1.03
Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010. Vaccine (2013) 1.01
Detection and typing of lymphotropic herpesviruses by multiplex polymerase chain reaction. J Virol Methods (1999) 1.01
Inhibition of superoxide production in B lymphocytes by rac antisense oligonucleotides. J Biol Chem (1992) 1.00
Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine. Arch Virol (1992) 1.00
N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonists. J Med Chem (1997) 1.00
Ongoing rubella outbreak among adolescents in Salaj, Romania, September 2011-January 2012. Euro Surveill (2012) 0.99
Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders. J Clin Microbiol (2000) 0.99
Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia. J Urol (1999) 0.98
Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus. Am J Physiol Heart Circ Physiol (2001) 0.98
Role of caspases and possible involvement of retinoblastoma protein during TGFbeta-mediated apoptosis of human B lymphocytes. Oncogene (1999) 0.98
Influenza pandemic: preparedness planning in Germany. Euro Surveill (2002) 0.98
A large rubella outbreak, Romania--2003. Euro Surveill (2004) 0.95
Radioimmunoassayable serum LH and FSH in girls with sexual precocity, premature thelarche and adrenarche. J Clin Endocrinol Metab (1969) 0.94
A summer school on vaccinology: Responding to identified gaps in pre-service immunisation training of future health care workers. Vaccine (2009) 0.93
Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation. J Immunol (1987) 0.93
Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene (1995) 0.93
Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by bcl-2. Cell Death Differ (1999) 0.92
Twenty-four hour hypothermic machine perfusion preservation of porcine pancreas facilitates processing for islet isolation. Transplant Proc (2008) 0.92
Detection of both herpes simplex and varicella-zoster viruses in cerebrospinal fluid from patients with encephalitis. J Med Virol (1996) 0.92
p38 MAPK and MSK1 mediate caspase-8 activation in manganese-induced mitochondria-dependent cell death. Cell Death Differ (2007) 0.91
Multiplex polymerase chain reaction for the simultaneous detection and typing of polyomavirus JC, BK and SV40 DNA in clinical samples. J Virol Methods (1999) 0.90
[Prevalence of hantavirus infections in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2004) 0.90
B cell differentiation and interleukin 2 (IL2): corticosteroids interact with monocytes to enhance the effect of IL2. Eur J Immunol (1987) 0.89
Zinc-mediated regulation of caspases activity: dose-dependent inhibition or activation of caspase-3 in the human Burkitt lymphoma B cells (Ramos). Cell Death Differ (2001) 0.89
Trends in hepatitis B incidence in Romania, 1989-2005. Euro Surveill (2008) 0.89
Stability of 17D yellow fever virus vaccine using different stabilizers. Biologicals (1998) 0.88
Prior rituximab administration is associated with reduced rate of acute GVHD after in vivo T-cell depleted transplantation in lymphoma patients. Exp Hematol (2011) 0.88
Detection and subtyping of dengue 1-4 and yellow fever viruses by means of a multiplex RT-nested-PCR using degenerated primers. Trop Med Int Health (2006) 0.88
Rapid quantification and differentiation of human polyomavirus DNA in undiluted urine from patients after bone marrow transplantation. J Clin Microbiol (2000) 0.88
Evaluation of the use of RT-PCR for the early diagnosis of dengue fever. Clin Microbiol Infect (2006) 0.87
Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents. J Antimicrob Chemother (1999) 0.87
Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood (1996) 0.87
Acute double blind trial of a new anti-anginal drug: molsidomine. Eur J Clin Pharmacol (1978) 0.87
Functional heterogeneity of B-CLL lymphocytes: dissociated responsiveness to growth factors and distinct requirements for a first activation signal. Blood (1987) 0.86
West Nile virus circulation in South-Eastern Romania, 2011 to 2013. Euro Surveill (2015) 0.86
Ongoing activity of Toscana virus genotype A and West Nile virus lineage 1 strains in Turkey: a clinical and field survey. Zoonoses Public Health (2013) 0.86
Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles. Virology (1996) 0.86
Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. Mol Med (1997) 0.86
Inactivation of HIV, HBV, HCV related viruses and other viruses in human plasma derivatives by pasteurisation. Dev Biol Stand (1993) 0.86
Novel diversity in IL-4-mediated responses in resting human naive B cells versus germinal center/memory B cells. J Immunol (2000) 0.85
Cdk2 associates with MAP kinase in vivo and its nuclear translocation is dependent on MAP kinase activation in IL-2-dependent Kit 225 T lymphocytes. Oncogene (2000) 0.85
Respiratory burst in human B lymphocytes. Triggering of surface Ig receptors induces modulation of chemiluminescence signal. J Immunol (1991) 0.85
Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation. J Immunol (1997) 0.85
First epidemic of aseptic meningitis due to echovirus type 13 among Spanish children. Epidemiol Infect (2003) 0.85
Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus. J Clin Microbiol (2005) 0.84
Viral diagnosis of neurological infection by RT multiplex PCR: a search for entero- and herpesviruses in a prospective study. J Med Virol (1999) 0.84
Production of growth factors by human myeloma cells. Cancer Res (1987) 0.84
A Belgian traveler who acquired yellow fever in the Gambia. Clin Infect Dis (2002) 0.84
Tick-borne encephalitis in Europe, 2007 to 2009. Euro Surveill (2011) 0.84
Determinants of tick-borne encephalitis virus antibody presence in roe deer (Capreolus capreolus) sera. Med Vet Entomol (2011) 0.84
Human B cell activation: selective sensitivity of the early stages to calcium channel-blocking drugs. Eur J Immunol (1986) 0.84
JC virus and human colon carcinoma: an intriguing and inconclusive association. Gastroenterology (2003) 0.84